Germany Platelet Rich Plasma (prp) Market Size & Outlook
Germany platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Germany platelet rich plasma (prp) market highlights
- The Germany platelet rich plasma (prp) market generated a revenue of USD 37.4 million in 2023 and is expected to reach USD 107.6 million by 2030.
- The Germany market is expected to grow at a CAGR of 16.3% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 37.4 million |
| Market revenue in 2030 | USD 107.6 million |
| Growth rate | 16.3% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Germany accounted for 5.8% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.6% in 2023. Horizon Databook has segmented the Germany platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the major countries contributing to the revenue generation in Europe. The presence of strong research for PRP therapies is a major factor contributing to market growth in the country. For instance, a group of researchers from various research and academic institutes in the country published a study in May 2019.
According to this study, intra-articular injection of PRP can improve osteoarthritis symptoms with a reduction in pain independent of the level of cartilage damage. Such research studies are anticipated to support the adoption of PRP therapies in the country, leading to considerable market growth.
In addition, in September 2020, a survey was conducted by a group of scientists from the German Society of Orthopedics and Traumatology's "Working Group for Clinical Tissue Regeneration." This study illustrated the need for standardization of PRP preparation methods, application, and indication protocols for knee osteoarthritis & other indications.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Germany Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
